- Report
- November 2025
- 183 Pages
Global
From €4056EUR$4,500USD£3,485GBP
- Report
- September 2026
- 192 Pages
Global
From €3196EUR$3,545USD£2,746GBP
€3551EUR$3,939USD£3,051GBP
- Report
- August 2026
- 160 Pages
Global
From €2993EUR$3,320USD£2,571GBP
€3741EUR$4,150USD£3,214GBP
- Report
- October 2025
- 163 Pages
Global
From €3500EUR$4,159USD£3,112GBP
- Report
- January 2026
- 180 Pages
Global
From €3196EUR$3,545USD£2,746GBP
€3551EUR$3,939USD£3,051GBP
- Report
- February 2026
- 250 Pages
Global
From €4047EUR$4,490USD£3,477GBP
- Report
- May 2026
- 400 Pages
Global
From €3488EUR$3,869USD£2,997GBP
- Report
- August 2026
- 950 Pages
Global
From €4503EUR$4,995USD£3,869GBP
- Report
- September 2026
- 281 Pages
Global
From €6306EUR$6,995USD£5,418GBP
- Report
- December 2025
- 391 Pages
Global
From €4326EUR$4,799USD£3,717GBP
- Report
- October 2025
- 598 Pages
Global
From €4326EUR$4,799USD£3,717GBP
- Report
- April 2026
- 424 Pages
Global
From €5240EUR$6,017USD£4,350GBP
- Report
- February 2026
- 320 Pages
Global
From €4462EUR$4,950USD£3,834GBP
- Report
- December 2025
- 250 Pages
Global
From €4326EUR$4,799USD£3,717GBP
- Report
- October 2025
- 204 Pages
Global
From €4326EUR$4,799USD£3,717GBP
- Report
- June 2026
- 800 Pages
Global
From €2704EUR$3,000USD£2,323GBP
- Report
- May 2026
- 1200 Pages
Global
From €4507EUR$5,000USD£3,872GBP
- Report
- April 2026
- 100 Pages
Global
From €2975EUR$3,300USD£2,556GBP
- Report
- January 2026
- 270 Pages
Global
From €2524EUR$2,800USD£2,169GBP
- Report
- November 2025
- 120 Pages
Global
From €2975EUR$3,300USD£2,556GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more